Pharma Capital

WideCells Group CEO Joao Andrade 'very pleased' with investor response to £649k raise

Joao Andrade, chief executive of WideCells Group PLC (LON:WDC) tells Proactive the stem cell storage specialist has raised £649,000 through a private placing to speed up development of its three main divisions, CellPlan, WideCells and WideAcademy.

 

View full WDC profile

WideCells Group Timeline

Newswire

WideCells appoints Apple education guru

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.